tirzepatide and hypoglycemia Glycemic Variability with Significantly Lower vs Degludec as Assessed by CGM The Science Behind Tirzepatide: GLP-1

In strict economic terms, NICE and ICER agree about the basic goal (maximize health per dollar) but differ on who pays and how much they will pay before that equation breaks down

Fallon Community Health Plan: KEY DRIVERS FOR THE PROPOSED RATE CHANGE The 9.9% rate change is driven by the following key components: 9.8% rate increase due to the risk adjustment transfer -3.0% reduction due to base period cost and trend restatement 3.5% attributed to claim cost increases due to enhanced subsidy expiration and Connector Care expiration -0.4% reduction due to administrative costs Harvard Pilgrim Health Care: KEY DRIVERS FOR THE PROPOSED RATE CHANGE Medical Trend : A key driver of health insurance premium increases year-over-year is medical trend, which is comprised of inpatient, outpatient, and physician services

Ultimately, Wilson lost more than 60 lbs by being more active

Tennessee patients benefit from genetic insights that inform whether standard semaglutide dosing aligns with their individual biology or whether alternative compounds like tirzepatide might offer superior outcomes

Results: Mounjaro: 20.2% average weight loss Wegovy: 13.7% average weight loss Waist circumference reduction: 18.4cm (Mounjaro) vs 13.0cm (Wegovy) Achieving 20%+ weight loss: 1 in 3 Mounjaro patients vs significantly fewer on Wegovy Thats about 47% more weight loss on average with Mounjaro